Part 9: The Challenges of Developing Vaccines and Treatments for COVID-19

June 1, 2020

In this webinar, our expert speakers turn their attention to challenges of doing research on the COVID-19 pandemic. They discuss:

  • The remdesivir development pathway and the experience of designing and conducting clinical trials in a brand-new disease without the benefit of medical guidance or regulatory precedent
  • The status and future of prophylactic vaccine development for COVID-19
  • The ethical issues of human challenge studies, which can speed vaccine development timelines but require careful consideration because they would intentionally expose study volunteers to COVID-19
Previous Flipbook
Part 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines
Part 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines

Next Flipbook
Part 8: The Realities of Restart
Part 8: The Realities of Restart